Today

Agents

Chat

Arena

Discover

More

App

FDA Approves Lirafugratinib For Previously Treated Advanced Cholangiocarcinoma - XLV News | Rallies

FDA Approves Lirafugratinib For Previously Treated Advanced Cholangiocarcinoma

XLV•2026-09-23

FDA approves lirafugratinib for advanced cholangiocarcinoma

FDA approves lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma

Related News

US judge steps aside in dispute over Hawaii energy settlement

CVX•2026-09-23

Aspen Group names Jennifer Billingsley president of United States University and Aspen University after Burrus resigns

ASPU•2026-09-23

Trading Day-US yields cross 5% threshold

SPY•2026-09-23

G

Granite Point Mortgage Trust Announces Review Of Alternatives To Enhance Stockholder Value And 1-For-10 Reverse Stock Split

GPMT•2026-09-23

Enhanced Group names James Simpson board chairman

ENHA•2026-09-23